{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1190"},{"groupId":"OG001","value":"17"}]}],"title":"No history for antibiotic use for CIN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"24"}]}],"title":"History for antibiotic use for CIN (Yes)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"1192"},{"groupId":"OG001","value":"41"}],"units":"Participants"}],"description":"Objective 7: To identify different latent clusters of end-stage cancer patients receiving chemotherapy and being treated with EP2006 for the treatment or primary or secondary prophylaxis of FN using statistical data-mining techniques to profile patients based on medical history, concomitant comorbid conditions, and current clinical status.\n\nCIN=Chemotherapy Induced Neutropenia; FN=Febrile Neutropenia","groups":[{"description":"Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN.","id":"OG000","title":"EP2006 - Group 1"},{"description":"Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN.","id":"OG001","title":"EP2006 - Group 2"}],"paramType":"NUMBER","populationDescription":"A two-group solution converged and the groups differentiated on key baseline variables. However, the group sizes were too unevenly distributed for further analysis with the \"high risk group\" comprised of only 3.0% of the evaluable sample.\n\nOnly patients with data in each group are analyzed for history of antibiotic use for CIN.","reportingStatus":"POSTED","timeFrame":"Enrollment cycle. Patients were evaluated at the enrollment cycle and then re-evaluated at each cycle for a maximum total of 6 cycles; however, the scheduling of these evaluations was left to the discretion of the physician.","title":"Characteristics of Clusters: History of Antibiotic Use for CIN","type":"SECONDARY","unitOfMeasure":"participants"}